Table I.
Patient characteristics between pre-COVID ICU patients and COVID-19 ICU patients. Categorical variables are presented as total number with percentages; nonnormally distributed continuous variables are expressed as mean with IQR
| Pre-Covid 2019 N = 249 | COVID-19 N = 249 | P-value | |
|---|---|---|---|
| Demographics | |||
| Agea | 60 (48, 73) | 60 (49, 69) | 0.643 |
| Male (%) | 136 (54.6%) | 145 (58.2%) | 0.416 |
| BMI | 27.5 (23.5, 32.2) | 30.8 (27, 36) | <0.001 |
| Ethnicity | - | - | <0.001 |
| White | 73 | 14 | - |
| African American | 38 | 11 | - |
| Hispanic | 130 | 201 | - |
| Asian | 5 | 21 | - |
| Native American | 3 | 2 | - |
| Comorbid Conditions | |||
| Diabetes Mellitus (%) | 92 (36.9%) | 141 (56.6%) | <0.001 |
| Hypertension (%) | 147 (59%) | 122 (48.9%) | 0.025 |
| Hyperlipidemia (%) | 67 (26.9%) | 75 (30.1%) | 0.427 |
| Chronic Kidney Disease (%) | 32 (12.9%) | 37 (14.9%) | 0.517 |
| End Stage Renal Disease (%) | 18 (7.2%) | 19 (7.6%) | 0.864 |
| Congestive Heart Failure (%) | 26 (10.4%) | 30 (12%) | 0.570 |
| Coronary Artery Disease (%) | 41 (16.5%) | 58 (23.3%) | 0.056 |
| Chronic Obstructive Pulmonary Disease (%) | 16 (6.4%) | 21 (8.4%) | 0.568 |
| Asthma (%) | 10 (4%) | 10 (4%) | 1.000 |
| Cerebrovascular Disease (%) | 86 (34.5%) | 13 (5.2%) | <0.001 |
| Cirrhosis (%) | 9 (3.6%) | 5 (2%) | 0.278 |
| Dementia (%) | 9 (3.6%) | 4 (1.6%) | 0.160 |
| Arterial Disease (%) | 13 (5.2%) | 52 (20.8%) | <0.001 |
| Venous Disease (%) | 8 (3.2%) | 4 (1.6%) | 0.242 |
| Hypercoagulable State (%) | 7 (2.8%) | 40 (16%) | <0.001 |
| Smoking (%) | 93 (37.3%) | 24 (9.6%) | <0.001 |
| Medication Use | |||
| Aspirin (%) | 75 (30%) | 71 (28.5%) | 0.694 |
| Clopidogrel (%) | 31 (12.4%) | 19 (7.6%) | 0.074 |
| Other Antiplatelet (%) | 2 (0.8%) | 0 | 0.156 |
| Coumadin (%) | 4 (1.6%) | 8 (3.2%) | 0.242 |
| Direct Oral Anticoagulant (%) | 17 (6.8%) | 12 (4.8%) | 0.339 |
| Statin (%) | 86 (34.5%) | 62 (24.9%) | 0.019 |
Significant differences are bolded.
a
Analyzed with nonparametric Mann Whitney U test. All other comparisons were analyzed with chi-squared test.